Molecular features of the complementarity determining region 3 motif of the T cell population and subsets in the blood of patients with chronic severe hepatitis B

Journal of Translational Medicine

Volumn 9, Issue 1, 2011, Pages

  Yang, Jiezuan ^a   He, Jianqin ^a   Lu, Haifeng ^a   Wei, Li ^a   Li, Sujun ^b   Wang, Baohong ^a   Diao, Hongyan ^a   Li, Lanjuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR BETA CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; AMINO ACID ANALYSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CHRONIC SEVERE HEPATITIS B; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; COMPLEMENTARITY DETERMINING REGION 3; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DISEASE SEVERITY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; GENE LOCATION; GENE MELTING SPECTRAL PATTERN ASSAY; GENE SEQUENCE; HEPATITIS B; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MALE; MOLECULAR CLONING; MOLECULAR PATHOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE SUBPOPULATION; AMINO ACID SEQUENCE; BLOOD; CHEMISTRY; DNA DENATURATION; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; MIDDLE AGED; MOLECULAR GENETICS; PROTEIN MOTIF; T LYMPHOCYTE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; COMPLEMENTARITY DETERMINING REGIONS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NUCLEIC ACID DENATURATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 82955188803     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-210     Document Type: Article

References (32)

1. Organization WH Department of Communicable diseases surveillance and response. Hepatitis B. Who Fact Sheets 2004, Organization WH.
2. Liaw YF. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int 2009, 29(Suppl 1):100-107.
3. Wei L. Natural history of chronic hepatitis B virus infection: what determines prognosis after cirrhotic decompensation?. J Gastroenterol Hepatol 2008, 23:1631-1632. 10.1111/j.1440-1746.2008.05576.x, 19120855.
4. Miqueu P, Guillet M, Degauque N, Dore JC, Soulillou JP, Brouard S. Statistical analysis of CDR3 length distributions for the assessment of T and B cell repertoire biases. Mol Immunol 2007, 44:1057-1064. 10.1016/j.molimm.2006.06.026, 16930714.
5. Melenhorst JJ, Lay MDH, Price DA, Adams SD, Zeilah J, Sosa E, Hensel NF, Follmann D, Douek DC, Davenport MP, Barrett AJ. Contribution of TCR-β locus and HLA to the shape of the mature human Vβ repertoire. Journal of Immunology 2008, 180:6484-6489.
6. Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med 2011, 365:725-733. 10.1056/NEJMoa1103849, 21830940.
7. Imamura T, Yokosuka O, Kurihara T, Kanda T, Fukai K, Imazeki F, Saisho H. Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan. Gut 2003, 52:1630-1637. 10.1136/gut.52.11.1630, 1773865, 14570734.
8. Chen Y, Li X, Ye B, Yang X, Wu W, Chen B, Pan X, Cao H, Li L. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B. Antiviral Res 2011, 91:23-31. 10.1016/j.antiviral.2011.04.008, 21549152.
9. Yang JZ, Li MW, Wang JG, Lu HF, Yao XS, He JQ, Li LJ. Rapid detection of clonal expansion of T-cell receptor-beta gene in patients with HBV using the real-time PCR with DNA melting curve analysis. Hepatol Res 2010, 40:407-414. 10.1111/j.1872-034X.2009.00600.x, 20070405.
10. Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 2006, 43:S173-181. 10.1002/hep.20956, 16447285.
11. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology 2009, 49:S45-55. 10.1002/hep.22898, 19399792.
12. Komatsu H, Inui A, Sogo T, Hiejima E, Tateno A, Klenerman P, Fujisawa T. Cellular immunity in children with successful immunoprophylactic treatment for mother-to-child transmission of hepatitis B virus. BMC Infect Dis 2010, 10:103. 10.1186/1471-2334-10-103, 2879245, 20423521.
13. Kreslavsky T, Gleimer M, Garbe AI, von Boehmer H. alphabeta versus gammadelta fate choice: counting the T-cell lineages at the branch point. Immunol Rev 2010, 238:169-181. 10.1111/j.1600-065X.2010.00947.x, 3031133, 20969592.
14. Marrack P, Kappler J. Positive selection of thymocytes bearing alpha beta T cell receptors. Curr Opin Immunol 1997, 9:250-255. 10.1016/S0952-7915(97)80144-6, 9099796.
15. Okajima M, Wada T, Nishida M, Yokoyama T, Nakayama Y, Hashida Y, Shibata F, Tone Y, Ishizaki A, Shimizu M, Saito T, Ohta K, Toma T, Yachie A. Analysis of T cell receptor Vbeta diversity in peripheral CD4 and CD8 T lymphocytes in patients with autoimmune thyroid diseases. Clin Exp Immunol 2009, 155:166-172. 10.1111/j.1365-2249.2008.03842.x, 2675246, 19040601.
16. Du JW, Gu JY, Liu J, Cen XN, Zhang Y, Ou Y, Chu B, Zhu P. TCR spectratyping revealed T lymphocytes associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma 2007, 48:1618-1627. 10.1080/10428190701474357, 17701594.
17. Spicuglia S, Pekowska A, Zacarias-Cabeza J, Ferrier P. Epigenetic control of Tcrb gene rearrangement. Semin Immunol 2010, 22:330-336. 10.1016/j.smim.2010.07.002, 20829066.
18. Long SA, Khalili J, Ashe J, Berenson R, Ferrand C, Bonyhadi M. Standardized analysis for the quantification of Vbeta CDR3 T-cell receptor diversity. J Immunol Methods 2006, 317:100-113. 10.1016/j.jim.2006.09.015, 17081557.
19. Pilch H, Hohn H, Freitag K, Neukirch C, Necker A, Haddad P, Tanner B, Knapstein PG, Maeurer MJ. Improved assessment of T-cell receptor (TCR) VB repertoire in clinical specimens: combination of TCR-CDR3 spectratyping with flow cytometry-based TCR VB frequency analysis. Clin Diagn Lab Immunol 2002, 9:257-266. 119929, 11874861.
20. Ochsenreither S, Fusi A, Busse A, Nagorsen D, Schrama D, Becker J, Thiel E, Keilholz U. Relative quantification of TCR Vbeta-chain families by real time PCR for identification of clonal T-cell populations. J Transl Med 2008, 6:34. 10.1186/1479-5876-6-34, 2467404, 18593466.
21. Seo KS, Park JY, Terman DS, Bohach GA. A quantitative real time PCR method to analyze T cell receptor Vbeta subgroup expansion by staphylococcal superantigens. J Transl Med 2010, 8:2. 10.1186/1479-5876-8-2, 2841588, 20070903.
22. Sun W, Nie H, Li N, Zang YC, Zhang D, Feng G, Ni L, Xu R, Prasad S, Robinson RR, Ho W, Sercarz E, Zhang JZ. Skewed T-cell receptor BV14 and BV16 expression and shared CDR3 sequence and common sequence motifs in synovial T cells of rheumatoid arthritis. Genes Immun 2005, 6:248-261. 10.1038/sj.gene.6364166, 15674392.
23. Das A, Hoare M, Davies N, Lopes AR, Dunn C, Kennedy PT, Alexander G, Finney H, Lawson A, Plunkett FJ, Bertoletti A, Akbar AN, Maini MK. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med 2008, 205:2111-2124. 10.1084/jem.20072076, 2526205, 18695005.
24. Kerkar SP, Sanchez-Perez L, Yang S, Borman ZA, Muranski P, Ji Y, Chinnasamy D, Kaiser AD, Hinrichs CS, Klebanoff CA, Scott CD, Gattinoni L, Morgan RA, Rosenberg SA, Restifo NP. Genetic engineering of murine CD8(+) and CD4(+) T cells for preclinical adoptive immunotherapy studies. J Immunother 2011, 34:343-352. 10.1097/CJI.0b013e3182187600, 21499127.
25. Bendle GM, Haanen JB, Schumacher TN. Preclinical development of T cell receptor gene therapy. Curr Opin Immunol 2009, 21:209-214. 10.1016/j.coi.2009.02.007, 19321326.
26. A V-R. Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nat Med 2008, 14:1390-1395. 10.1038/nm.1779, 3008216, 18997777.
27. Wang QJ, Hanada K, Feldman SA, Zhao Y, Inozume T, Yang JC. Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinoma. J Immunol Methods 2011, 366:43-51. 10.1016/j.jim.2011.01.002, 21255579.
28. Frankel TL, Burns WR, Peng PD, Yu Z, Chinnasamy D, Wargo JA, Zheng Z, Restifo NP, Rosenberg SA, Morgan RA. Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase. J Immunol 2010, 184:5988-5998. 10.4049/jimmunol.1000189, 20427771.
29. Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, Rosenberg SA. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006, 314:126-129. 10.1126/science.1129003, 2267026, 16946036.
30. Gehring AJ, Xue SA, Ho ZZ, Teoh D, Ruedl C, Chia A, Koh S, Lim SG, Maini MK, Stauss H, Bertoletti A. Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines. J Hepatol 2011, 55:103-110. 10.1016/j.jhep.2010.10.025, 21145860.
31. Jorritsma A, Schotte R, Coccoris M, de Witte MA, Schumacher TN. Prospects and limitations of T cell receptor gene therapy. Curr Gene Ther 2011, 11:276-287. 10.2174/156652311796150390, 21453279.
32. Hui CK, Leung N, Yuen ST, Zhang HY, Leung KW, Lu L, Cheung SK, Wong WM, Lau GK. Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. Hepatology 2007, 46:395-401.